123 related articles for article (PubMed ID: 36177826)
1. Corrigendum: A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202211958. PubMed ID: 36177826
[No Abstract] [Full Text] [Related]
2. A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
Angew Chem Int Ed Engl; 2020 Jan; 59(3):1108-1112. PubMed ID: 31642163
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides.
Zhang H; Chen W; Gong K; Chen J
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289
[TBL] [Abstract][Full Text] [Related]
6. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.
Jahrsdörfer B; Weiner GJ
Curr Opin Investig Drugs; 2003 Jun; 4(6):686-90. PubMed ID: 12901226
[TBL] [Abstract][Full Text] [Related]
8. CpG oligodeoxynucleotides as immunotherapy in cancer.
Jahrsdörfer B; Weiner GJ
Update Cancer Ther; 2008 Mar; 3(1):27-32. PubMed ID: 19255607
[TBL] [Abstract][Full Text] [Related]
9. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
10. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer.
Makkouk A; Joshi VB; Wongrakpanich A; Lemke CD; Gross BP; Salem AK; Weiner GJ
AAPS J; 2015 Jan; 17(1):184-93. PubMed ID: 25331103
[TBL] [Abstract][Full Text] [Related]
12. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
13. Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy.
Fan Z; Liu H; Xue Y; Lin J; Fu Y; Xia Z; Pan D; Zhang J; Qiao K; Zhang Z; Liao Y
Bioact Mater; 2021 Feb; 6(2):312-325. PubMed ID: 32954050
[TBL] [Abstract][Full Text] [Related]
14. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
Ni K; Lan G; Guo N; Culbert A; Luo T; Wu T; Weichselbaum RR; Lin W
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008911
[TBL] [Abstract][Full Text] [Related]
15. Effective CpG Delivery Using Zwitterion-Functionalized Dendrimer-Entrapped Gold Nanoparticles to Promote T Cell-Mediated Immunotherapy of Cancer Cells.
Chen H; Zhang Y; Li L; Guo R; Shi X; Cao X
Biosensors (Basel); 2022 Jan; 12(2):. PubMed ID: 35200332
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-functionalized nanoscale metal-organic frameworks for targeted photodynamic therapy.
Meng HM; Hu XX; Kong GZ; Yang C; Fu T; Li ZH; Zhang XB
Theranostics; 2018; 8(16):4332-4344. PubMed ID: 30214624
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment.
Liu J; Yang Y; Zhu W; Yi X; Dong Z; Xu X; Chen M; Yang K; Lu G; Jiang L; Liu Z
Biomaterials; 2016 Aug; 97():1-9. PubMed ID: 27155362
[TBL] [Abstract][Full Text] [Related]
18. DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses.
Yang Y; Liu B; Liu Y; Chen J; Sun Y; Pan X; Xu J; Xu S; Liu Z; Tan W
Nano Lett; 2022 Apr; 22(7):2826-2834. PubMed ID: 35344667
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
Zhong XF; Sun X
Acta Pharmacol Sin; 2020 Jul; 41(7):928-935. PubMed ID: 32355277
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
Li J; Song W; Czerwinski DK; Varghese B; Uematsu S; Akira S; Krieg AM; Levy R
J Immunol; 2007 Aug; 179(4):2493-500. PubMed ID: 17675511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
